Published in Neurology on December 23, 2003
Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research. Am J Psychiatry (2008) 2.37
Medical decision-making capacity in mild cognitive impairment: a 3-year longitudinal study. Neurology (2008) 1.25
Research ethics issues in geriatric psychiatry. Psychiatr Clin North Am (2009) 0.85
Meta-consent in research on decisional capacity: a "Catch-22"? Schizophr Bull (2005) 0.84
Informed consent: the rate-limiting step in acute stroke trials. Front Neurol (2011) 0.83
Understanding of informed consent by demented individuals. Neurology (2003) 1.31
Are the rules for research with subjects with dementia changing?: views from the field. Neurology (2003) 1.19
The continuing unethical conduct of underpowered clinical trials. JAMA (2002) 10.34
Advance directives and outcomes of surrogate decision making before death. N Engl J Med (2010) 7.09
Informed consent for pragmatic trials--the integrated consent model. N Engl J Med (2014) 3.01
Current state of research on decision-making competence of cognitively impaired elderly persons. Am J Geriatr Psychiatry (2002) 3.00
Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med (2004) 2.49
What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports. Neurology (2005) 2.25
Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J (2003) 1.89
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med (2003) 1.68
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations. Lancet Neurol (2012) 1.54
Why doesn't a family member of a person with advanced dementia use a substituted judgment when making a decision for that person? Am J Geriatr Psychiatry (2006) 1.46
Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev (2011) 1.32
Assessment of decision-making capacity: views and experiences of consultation psychiatrists. Psychosomatics (2012) 1.29
Returning individual research results: development of a cancer genetics education and risk communication protocol. J Empir Res Hum Res Ethics (2010) 1.22
Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey. Ann Intern Med (2015) 1.20
The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry (2008) 1.19
Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials. Am J Geriatr Psychiatry (2008) 1.10
Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale. Alzheimer Dis Assoc Disord (2009) 1.09
The development of a rapid screen for caregiver burden. J Am Geriatr Soc (2004) 1.06
Is psychiatric research stigmatized? An experimental survey of the public. Schizophr Bull (2005) 1.02
How does an Alzheimer's disease patient's role in medical decision making change over time? J Geriatr Psychiatry Neurol (2004) 1.01
What's it worth? Public willingness to pay to avoid mental illnesses compared with general medical illnesses. Psychiatr Serv (2012) 1.00
Measuring how people view biomedical research: Reliability and validity analysis of the Research Attitudes Questionnaire. J Empir Res Hum Res Ethics (2011) 0.96
Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them? Gerontologist (2005) 0.93
Ethics of sham surgery: perspective of patients. Mov Disord (2008) 0.92
Identifying ambulatory cancer patients at risk of impaired capacity to consent to research. J Pain Symptom Manage (2003) 0.92
A framework for assessing the quality of democratic deliberation: enhancing deliberation as a tool for bioethics. J Empir Res Hum Res Ethics (2011) 0.89
How do patients with Alzheimer disease rate their overall quality of life? Am J Geriatr Psychiatry (2005) 0.88
Clinical value: the neglected axis in the system of research ethics. Account Res (1999) 0.87
A taxonomy of value in clinical research. IRB (2003) 0.85
Long term understanding of study information in research participants with Parkinson's disease. Parkinsonism Relat Disord (2009) 0.84
Ignoring the controversies: newspaper reports on Alzheimer's disease treatments. J Am Geriatr Soc (2003) 0.84
Identifying the factors that facilitate or hinder advance planning by persons with dementia. Alzheimer Dis Assoc Disord (2008) 0.84
Waivers and Alterations to Consent in Pragmatic Clinical Trials: Respecting the Principle of Respect for Persons. IRB (2016) 0.83
Are depressed patients more likely to share health care decisions with others? J Palliat Med (2004) 0.82
Must patients with advanced cancer choose between a Phase I trial and hospice? Cancer (2002) 0.82
What is good public deliberation? Hastings Cent Rep (2012) 0.79
Who can speak for the emergently ill? Testing a method to identify communities and their leaders. Acad Emerg Med (2008) 0.79
Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment. Am J Geriatr Psychiatry (2013) 0.79
Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication? Am J Geriatr Psychiatry (2005) 0.79
Off-label use of therapeutic hypothermia for infants with hypoxic-ischemic encephalopathy. Virtual Mentor (2012) 0.79
Advocacy and activism: missing pieces in the quest to improve end-of-life care. J Palliat Med (2002) 0.78
Bioethics and the sociology of trust: introduction to the theme. Med Health Care Philos (2008) 0.78
Analysis of consent validity for invasive, nondiagnostic research procedures. IRB (2012) 0.77
Capacity to make decisions on medication management in Chinese older persons with mild cognitive impairment and mild Alzheimer's disease. Int Psychogeriatr (2012) 0.77
Substitute consent practices in the face of uncertainty: a survey of Canadian researchers in aging. Int Psychogeriatr (2013) 0.76
Is it research?: an increasingly common question. Neurology (2010) 0.76
Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem? IRB (2015) 0.76
Public's approach to surrogate consent for dementia research: cautious pragmatism. Am J Geriatr Psychiatry (2013) 0.76
Donepezil delay to nursing home placement study is flawed. J Am Geriatr Soc (2004) 0.76
Structured assessment of mental capacity to make financial decisions in Chinese older persons with mild cognitive impairment and mild Alzheimer disease. J Geriatr Psychiatry Neurol (2013) 0.76
Appointing a proxy for research consent after one develops dementia: the need for further study. Neurology (2006) 0.75
Re: "Ethics and sample size". Am J Epidemiol (2005) 0.75
Surrogate consent for dementia research: factors influencing five stakeholder groups from the SCORES study. IRB (2013) 0.75
Targeted Consent for Research on Standard of Care Interventions in the Emergency Setting. Crit Care Med (2017) 0.75
Evidence-based research ethics and determinations of "engagement in research". IRB (2014) 0.75
Patients' views on suicidality and antidepressants. Psychiatr Serv (2006) 0.75
Informing the consent process. Circ Cardiovasc Qual Outcomes (2008) 0.75
Cognitive function assessment in individuals at risk for Alzheimer's disease. J Am Acad Nurse Pract (2003) 0.75
Personal Care in Learning Health Care Systems. Kennedy Inst Ethics J (2015) 0.75